Compare Cintas Corporation (CTAS) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cintas Corporation vs Mesoblast Limited — how do they compare? Cintas Corporation trades at $205.28 (market cap $82.15B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: Cintas Corporation is far larger — about 37.2× Mesoblast Limited's market cap, and Cintas Corporation pays a 1.01% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| CTAS | MESO | |
|---|---|---|
Market Cap | $82.15B | $2.21B |
Sector | Industrials | Technology |
52-Week High | $225.10 | $20.96 |
52-Week Low | $163.55 | $12.88 |
Enterprise Value | $84.56B | $2.21B |
Dividend Yield | 1.01% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cintas Corporation
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
